(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 34.72% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of -5.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Gevo's revenue in 2024 is $17,200,000.On average, 3 Wall Street analysts forecast GEVO's revenue for 2024 to be $4,773,921,685, with the lowest GEVO revenue forecast at $4,569,496,827, and the highest GEVO revenue forecast at $4,990,371,535. On average, 3 Wall Street analysts forecast GEVO's revenue for 2025 to be $7,514,657,782, with the lowest GEVO revenue forecast at $5,771,995,992, and the highest GEVO revenue forecast at $8,494,454,102.
In 2026, GEVO is forecast to generate $10,072,133,006 in revenue, with the lowest revenue forecast at $5,771,995,992 and the highest revenue forecast at $14,372,270,020.